[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Healthcare-associated Infectious Disease Diagnostics Market - Global Outlook and Forecast 2021-2027

April 2021 | 100 pages | ID: H9E172662E8AEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Healthcare-associated Infectious Disease Diagnostics in Global, including the following market information:

Global Healthcare-associated Infectious Disease Diagnostics Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Healthcare-associated Infectious Disease Diagnostics market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Healthcare-associated Infectious Disease Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Healthcare-associated Infectious Disease Diagnostics Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Healthcare-associated Infectious Disease Diagnostics Market Segment Percentages, By Type, 2020 (%)
  • Urinary Tract Infections
  • Surgical Site Infections
  • Hospital-acquired Pneumonia
  • BloodStream Infections
  • Gastrointestinal Infections
China Healthcare-associated Infectious Disease Diagnostics Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Healthcare-associated Infectious Disease Diagnostics Market Segment Percentages, By Application, 2020 (%)
  • Hospitals
  • Clinics
  • ASCs
Global Healthcare-associated Infectious Disease Diagnostics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Healthcare-associated Infectious Disease Diagnostics Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Healthcare-associated Infectious Disease Diagnostics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Healthcare-associated Infectious Disease Diagnostics Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • Abbott
  • Accelerate Diagnostics
  • BD
  • bioMrieux
  • Bio-Rad
  • DiaSorin Molecular
  • F. Hoffmann-La Roche
  • Luminex
  • Meridian Bioscience
  • OpGen
  • QIAGEN
  • Quidel
  • Thermo Fisher Scientific
  • Trinity Biotech
  • Danaher
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Healthcare-associated Infectious Disease Diagnostics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Healthcare-associated Infectious Disease Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HEALTHCARE-ASSOCIATED INFECTIOUS DISEASE DIAGNOSTICS OVERALL MARKET SIZE

2.1 Global Healthcare-associated Infectious Disease Diagnostics Market Size: 2021 VS 2027
2.2 Global Healthcare-associated Infectious Disease Diagnostics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Healthcare-associated Infectious Disease Diagnostics Players in Global Market
3.2 Top Global Healthcare-associated Infectious Disease Diagnostics Companies Ranked by Revenue
3.3 Global Healthcare-associated Infectious Disease Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Healthcare-associated Infectious Disease Diagnostics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Healthcare-associated Infectious Disease Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Healthcare-associated Infectious Disease Diagnostics Players in Global Market
  3.6.1 List of Global Tier 1 Healthcare-associated Infectious Disease Diagnostics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Healthcare-associated Infectious Disease Diagnostics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Healthcare-associated Infectious Disease Diagnostics Market Size Markets, 2021 & 2027
  4.1.2 Urinary Tract Infections
  4.1.3 Surgical Site Infections
  4.1.4 Hospital-acquired Pneumonia
  4.1.5 BloodStream Infections
  4.1.6 Gastrointestinal Infections
4.2 By Type - Global Healthcare-associated Infectious Disease Diagnostics Revenue & Forecasts
  4.2.1 By Type - Global Healthcare-associated Infectious Disease Diagnostics Revenue, 2016-2021
  4.2.2 By Type - Global Healthcare-associated Infectious Disease Diagnostics Revenue, 2022-2027
  4.2.3 By Type - Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Healthcare-associated Infectious Disease Diagnostics Market Size, 2021 & 2027
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 ASCs
5.2 By Application - Global Healthcare-associated Infectious Disease Diagnostics Revenue & Forecasts
  5.2.1 By Application - Global Healthcare-associated Infectious Disease Diagnostics Revenue, 2016-2021
  5.2.2 By Application - Global Healthcare-associated Infectious Disease Diagnostics Revenue, 2022-2027
  5.2.3 By Application - Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Healthcare-associated Infectious Disease Diagnostics Market Size, 2021 & 2027
6.2 By Region - Global Healthcare-associated Infectious Disease Diagnostics Revenue & Forecasts
  6.2.1 By Region - Global Healthcare-associated Infectious Disease Diagnostics Revenue, 2016-2021
  6.2.2 By Region - Global Healthcare-associated Infectious Disease Diagnostics Revenue, 2022-2027
  6.2.3 By Region - Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Healthcare-associated Infectious Disease Diagnostics Revenue, 2016-2027
  6.3.2 US Healthcare-associated Infectious Disease Diagnostics Market Size, 2016-2027
  6.3.3 Canada Healthcare-associated Infectious Disease Diagnostics Market Size, 2016-2027
  6.3.4 Mexico Healthcare-associated Infectious Disease Diagnostics Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Healthcare-associated Infectious Disease Diagnostics Revenue, 2016-2027
  6.4.2 Germany Healthcare-associated Infectious Disease Diagnostics Market Size, 2016-2027
  6.4.3 France Healthcare-associated Infectious Disease Diagnostics Market Size, 2016-2027
  6.4.4 U.K. Healthcare-associated Infectious Disease Diagnostics Market Size, 2016-2027
  6.4.5 Italy Healthcare-associated Infectious Disease Diagnostics Market Size, 2016-2027
  6.4.6 Russia Healthcare-associated Infectious Disease Diagnostics Market Size, 2016-2027
  6.4.7 Nordic Countries Healthcare-associated Infectious Disease Diagnostics Market Size, 2016-2027
  6.4.8 Benelux Healthcare-associated Infectious Disease Diagnostics Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Healthcare-associated Infectious Disease Diagnostics Revenue, 2016-2027
  6.5.2 China Healthcare-associated Infectious Disease Diagnostics Market Size, 2016-2027
  6.5.3 Japan Healthcare-associated Infectious Disease Diagnostics Market Size, 2016-2027
  6.5.4 South Korea Healthcare-associated Infectious Disease Diagnostics Market Size, 2016-2027
  6.5.5 Southeast Asia Healthcare-associated Infectious Disease Diagnostics Market Size, 2016-2027
  6.5.6 India Healthcare-associated Infectious Disease Diagnostics Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Healthcare-associated Infectious Disease Diagnostics Revenue, 2016-2027
  6.6.2 Brazil Healthcare-associated Infectious Disease Diagnostics Market Size, 2016-2027
  6.6.3 Argentina Healthcare-associated Infectious Disease Diagnostics Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Revenue, 2016-2027
  6.7.2 Turkey Healthcare-associated Infectious Disease Diagnostics Market Size, 2016-2027
  6.7.3 Israel Healthcare-associated Infectious Disease Diagnostics Market Size, 2016-2027
  6.7.4 Saudi Arabia Healthcare-associated Infectious Disease Diagnostics Market Size, 2016-2027
  6.7.5 UAE Healthcare-associated Infectious Disease Diagnostics Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Abbott
  7.1.1 Abbott Corporate Summary
  7.1.2 Abbott Business Overview
  7.1.3 Abbott Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
  7.1.4 Abbott Healthcare-associated Infectious Disease Diagnostics Revenue in Global (2016-2021)
  7.1.5 Abbott Key News
7.2 Accelerate Diagnostics
  7.2.1 Accelerate Diagnostics Corporate Summary
  7.2.2 Accelerate Diagnostics Business Overview
  7.2.3 Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
  7.2.4 Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Revenue in Global (2016-2021)
  7.2.5 Accelerate Diagnostics Key News
7.3 BD
  7.3.1 BD Corporate Summary
  7.3.2 BD Business Overview
  7.3.3 BD Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
  7.3.4 BD Healthcare-associated Infectious Disease Diagnostics Revenue in Global (2016-2021)
  7.3.5 BD Key News
7.4 bioMrieux
  7.4.1 bioMrieux Corporate Summary
  7.4.2 bioMrieux Business Overview
  7.4.3 bioMrieux Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
  7.4.4 bioMrieux Healthcare-associated Infectious Disease Diagnostics Revenue in Global (2016-2021)
  7.4.5 bioMrieux Key News
7.5 Bio-Rad
  7.5.1 Bio-Rad Corporate Summary
  7.5.2 Bio-Rad Business Overview
  7.5.3 Bio-Rad Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
  7.5.4 Bio-Rad Healthcare-associated Infectious Disease Diagnostics Revenue in Global (2016-2021)
  7.5.5 Bio-Rad Key News
7.6 DiaSorin Molecular
  7.6.1 DiaSorin Molecular Corporate Summary
  7.6.2 DiaSorin Molecular Business Overview
  7.6.3 DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
  7.6.4 DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Revenue in Global (2016-2021)
  7.6.5 DiaSorin Molecular Key News
7.7 F. Hoffmann-La Roche
  7.7.1 F. Hoffmann-La Roche Corporate Summary
  7.7.2 F. Hoffmann-La Roche Business Overview
  7.7.3 F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
  7.4.4 F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Revenue in Global (2016-2021)
  7.7.5 F. Hoffmann-La Roche Key News
7.8 Luminex
  7.8.1 Luminex Corporate Summary
  7.8.2 Luminex Business Overview
  7.8.3 Luminex Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
  7.8.4 Luminex Healthcare-associated Infectious Disease Diagnostics Revenue in Global (2016-2021)
  7.8.5 Luminex Key News
7.9 Meridian Bioscience
  7.9.1 Meridian Bioscience Corporate Summary
  7.9.2 Meridian Bioscience Business Overview
  7.9.3 Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
  7.9.4 Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Revenue in Global (2016-2021)
  7.9.5 Meridian Bioscience Key News
7.10 OpGen
  7.10.1 OpGen Corporate Summary
  7.10.2 OpGen Business Overview
  7.10.3 OpGen Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
  7.10.4 OpGen Healthcare-associated Infectious Disease Diagnostics Revenue in Global (2016-2021)
  7.10.5 OpGen Key News
7.11 QIAGEN
  7.11.1 QIAGEN Corporate Summary
  7.11.2 QIAGEN Business Overview
  7.11.3 QIAGEN Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
  7.11.4 QIAGEN Healthcare-associated Infectious Disease Diagnostics Revenue in Global (2016-2021)
  7.11.5 QIAGEN Key News
7.12 Quidel
  7.12.1 Quidel Corporate Summary
  7.12.2 Quidel Business Overview
  7.12.3 Quidel Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
  7.12.4 Quidel Healthcare-associated Infectious Disease Diagnostics Revenue in Global (2016-2021)
  7.12.5 Quidel Key News
7.13 Thermo Fisher Scientific
  7.13.1 Thermo Fisher Scientific Corporate Summary
  7.13.2 Thermo Fisher Scientific Business Overview
  7.13.3 Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
  7.13.4 Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Revenue in Global (2016-2021)
  7.13.5 Thermo Fisher Scientific Key News
7.14 Trinity Biotech
  7.14.1 Trinity Biotech Corporate Summary
  7.14.2 Trinity Biotech Business Overview
  7.14.3 Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
  7.14.4 Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Revenue in Global (2016-2021)
  7.14.5 Trinity Biotech Key News
7.15 Danaher
  7.15.1 Danaher Corporate Summary
  7.15.2 Danaher Business Overview
  7.15.3 Danaher Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
  7.15.4 Danaher Healthcare-associated Infectious Disease Diagnostics Revenue in Global (2016-2021)
  7.15.5 Danaher Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Healthcare-associated Infectious Disease Diagnostics Market Opportunities & Trends in Global Market
Table 2. Healthcare-associated Infectious Disease Diagnostics Market Drivers in Global Market
Table 3. Healthcare-associated Infectious Disease Diagnostics Market Restraints in Global Market
Table 4. Key Players of Healthcare-associated Infectious Disease Diagnostics in Global Market
Table 5. Top Healthcare-associated Infectious Disease Diagnostics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Healthcare-associated Infectious Disease Diagnostics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Healthcare-associated Infectious Disease Diagnostics Revenue Share by Companies, 2016-2021
Table 8. Global Companies Healthcare-associated Infectious Disease Diagnostics Product Type
Table 9. List of Global Tier 1 Healthcare-associated Infectious Disease Diagnostics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Healthcare-associated Infectious Disease Diagnostics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Healthcare-associated Infectious Disease Diagnostics Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Healthcare-associated Infectious Disease Diagnostics Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Healthcare-associated Infectious Disease Diagnostics Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Healthcare-associated Infectious Disease Diagnostics Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2022-2027
Table 30. Abbott Corporate Summary
Table 31. Abbott Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 32. Abbott Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn), (2016-2021)
Table 33. Accelerate Diagnostics Corporate Summary
Table 34. Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 35. Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn), (2016-2021)
Table 36. BD Corporate Summary
Table 37. BD Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 38. BD Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn), (2016-2021)
Table 39. bioMrieux Corporate Summary
Table 40. bioMrieux Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 41. bioMrieux Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn), (2016-2021)
Table 42. Bio-Rad Corporate Summary
Table 43. Bio-Rad Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 44. Bio-Rad Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn), (2016-2021)
Table 45. DiaSorin Molecular Corporate Summary
Table 46. DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 47. DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn), (2016-2021)
Table 48. F. Hoffmann-La Roche Corporate Summary
Table 49. F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 50. F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn), (2016-2021)
Table 51. Luminex Corporate Summary
Table 52. Luminex Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 53. Luminex Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn), (2016-2021)
Table 54. Meridian Bioscience Corporate Summary
Table 55. Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 56. Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn), (2016-2021)
Table 57. OpGen Corporate Summary
Table 58. OpGen Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 59. OpGen Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn), (2016-2021)
Table 60. QIAGEN Corporate Summary
Table 61. QIAGEN Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 62. QIAGEN Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn), (2016-2021)
Table 63. Quidel Corporate Summary
Table 64. Quidel Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 65. Quidel Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn), (2016-2021)
Table 66. Thermo Fisher Scientific Corporate Summary
Table 67. Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 68. Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn), (2016-2021)
Table 69. Trinity Biotech Corporate Summary
Table 70. Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 71. Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn), (2016-2021)
Table 72. Danaher Corporate Summary
Table 73. Danaher Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 74. Danaher Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Healthcare-associated Infectious Disease Diagnostics Segment by Type
Figure 2. Healthcare-associated Infectious Disease Diagnostics Segment by Application
Figure 3. Global Healthcare-associated Infectious Disease Diagnostics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Healthcare-associated Infectious Disease Diagnostics Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Healthcare-associated Infectious Disease Diagnostics Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Healthcare-associated Infectious Disease Diagnostics Revenue in 2020
Figure 8. By Type - Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share, 2016-2027
Figure 9. By Application - Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share, 2016-2027
Figure 10. By Region - Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share, 2016-2027
Figure 11. By Country - North America Healthcare-associated Infectious Disease Diagnostics Revenue Market Share, 2016-2027
Figure 12. US Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Healthcare-associated Infectious Disease Diagnostics Revenue Market Share, 2016-2027
Figure 16. Germany Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 17. France Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Healthcare-associated Infectious Disease Diagnostics Revenue Market Share, 2016-2027
Figure 24. China Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 28. India Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Healthcare-associated Infectious Disease Diagnostics Revenue Market Share, 2016-2027
Figure 30. Brazil Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Revenue Market Share, 2016-2027
Figure 33. Turkey Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 37. Abbott Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. BD Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. bioMrieux Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Bio-Rad Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Luminex Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. OpGen Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. QIAGEN Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Quidel Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications